Find policies, billing codes, payers, states, and providers
Gender Affirming Surgery
Customize your policy alerts
Sign up for Aetna Policy 0615 alerts
Get alerted when Policy 0615 changes without checking for updates manually.
Monitor payer policy activity
This Clinical Policy Bulletin governs medical necessity criteria, covered and not-covered gender-affirming surgical procedures and related services for Aetna members; applicability may vary by specific benefit plan.
No material clinical or coverage changes in this revision.
Medical Necessity and Coverage Criteria
Medical necessity criteria by procedure group
Aetna considers gender affirming surgery medically necessary when criteria for each of the following procedures is met:
Clinical background and preparatory recommendations
Background clinical considerations referenced in document (no discrete coverage criteria in this section):
Descriptive background rather than prescriptive criteria.
Aetna considers the following procedures commonly performed as part of gender transition to be not medically necessary (cosmetic), unless otherwise specified by plan benefits: most hair removal (e.g., electrolysis, laser hair removal) except a limited number of sessions for skin graft preparation for genital surgery; tracheal shave (reduction thyroid chondroplasty); and many facial gender-affirming procedures including brow procedures, hairline advancement/hair transplant, facelift/mid-face lift (platysmaplasty), blepharoplasty, rhinoplasty (with or without fillers), cheek augmentation (implant or lipofilling), lip procedures (augmentation or shortening), lower jaw procedures, and chin reshaping (osteoplastic or implant-based). Body contouring procedures such as liposuction, implants (pectoral, hip, gluteal, calf) and related cosmetic procedures are also listed as not medically necessary when performed solely for gender affirmation.
Do not bill CPT 19303 (mastectomy for breast cancer) for chest masculinization/reduction mammaplasty in female-to-male (transmasculine) gender-affirming surgery. CPT guidance specifies that 19303 is intended for treatment or prevention of breast cancer and describes total removal of breast tissue; routine gender-affirming chest procedures typically preserve the nipple–areola complex and have different surgical objectives and documentation requirements.
Aetna considers more than one breast augmentation to be not medically necessary. This exclusion does not apply to medically necessary replacement of breast implants (for example, for device failure or complication) where replacement is documented as clinically indicated.
Coverage for facial gender-affirming surgery (FGAS) is variable across payers. Systematic review data show many commercial and Medicaid policies consider FGAS cosmetic; only a minority of state Medicaid programs include FGAS and many commercial policies either exclude or treat these procedures as cosmetic despite near-universal coverage for genital reconstruction in reviewed commercial policies.
CPT / HCPCS / ICD-10 Codes and Related Coding Notes
| 13131 | Repair, complex, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; 1.1 cm to 2.5 cm. |
| 13132 | Repair, complex; 2.6 cm to 7.5 cm. |
| 13133 | Repair, complex; each additional 5 cm or less. |
| 13160 | Secondary closure of surgical wound or dehiscence, extensive or complicated. |
| 14021 | Adjacent tissue transfer or rearrangement, scalp, arms and/or legs; defect 10.1 sq cm to 30.0 sq cm. |
| 14040 | Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less. |
| 14041 | Adjacent tissue transfer or rearrangement; defect 10.1 sq cm to 30.0 sq cm. |
| 14301 | Adjacent tissue transfer or rearrangement, any area; defect 30.1 sq cm to 60.0 sq cm. |
| 14302 | Adjacent tissue transfer or rearrangement, any area; each additional 30.0 sq cm, or part thereof. |
| 15002-15003 | Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar; trunk, arms, legs; first 100 sq cm or 1% of body area of infants and children. |
| 11950-11954 | Subcutaneous injection of filling material (e.g., collagen) - cosmetic/not covered. |
| 15200 | Full thickness graft, free, trunk; 20 sq cm or less [nipple reconstruction] - not covered when cosmetic. |
| 15775 | Punch graft for hair transplant; 1 to 15 punch grafts - not covered. |
| 15776 | Punch graft for hair transplant; more than 15 punch grafts - not covered. |
| 15780-15787 | Dermabrasion - not covered. |
| 15788-15793 | Chemical peel - not covered. |
| 15820-15823 | Blepharoplasty - not covered. |
| 15824-15828 | Rhytidectomy (face-lifting) - not covered. |
| 15830-15839 | Excision, excessive skin and subcutaneous tissue; abdomen, infraumbilical panniculectomy - not covered. |
| 15876-15879 | Suction assisted lipectomy - not covered. |
| C1789 | Prosthesis, breast (implantable). |
| C1813 | Prosthesis, penile, inflatable. |
| C2622 | Prosthesis, penile, non-inflatable. |
| J1071 | Injection, testosterone cypionate, 1 mg. |
| J3121 | Injection, testosterone enanthate, 1 mg. |
| J3145 | Injection, testosterone undecanoate, 1 mg. |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg. |
| J9202 | Goserelin acetate implant, per 3.6 mg. |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg. |
| J9218 | Leuprolide acetate, per 1 mg. |
| F64.0-F64.9 | Gender identity disorders. |
| Z87.890 | Personal history of sex reassignment. |
| Note1 | CPT codes for mastectomy (eg, 19303) are for breast cancer and are not appropriate to bill for reduction mammaplasty for female-to-male gender affirmation surgery. |
| Note2 | CPT 19318 (reduction mammaplasty) includes repositioning and reshaping of the nipple; CPT 19350 (nipple reconstruction) is incidental to 19318 and is generally not separately billable when performed at time of 19318. |
| Note3 | Graft codes (eg, 15200) and liposuction codes (eg, 15877) may be CCI 'incidental to' edits to 19318 and are included in 19318 when applicable. |
Authorization, Documentation, and Billing Guidance for Providers
Prior Authorization Required and Coverage Variability
Prior authorization is required for the gender-affirming procedures listed in the CPT/HCPCS code sections when applicable and when medical-necessity criteria in this policy are not clearly met. Coverage and prior authorization requirements vary by payer and by the member’s specific benefit plan; always verify benefits before scheduling.
- Prior authorization required for listed CPT/HCPCS codes when medical necessity criteria are not met or unclear
- Coverage varies by plan — check member-specific benefits and plan exclusions
Coverage Determined by Plan Benefits
Authorization and coverage determinations are governed by the member’s benefit plan terms. Even when procedures meet the medical necessity criteria in this policy, coverage is subject to the member’s contract, plan limits, and any applicable Clinical Policy Bulletins (CPBs).
- Benefits, limits, and exclusions in the member’s evidence of coverage control payment
- Clinical Policy Bulletins may further define coverage — verify applicability to the member’s plan
Denial Triggers — Cosmetic or Not Medically Necessary
Services that are cosmetic or otherwise not medically necessary per this policy will be denied. Examples include procedures identified as cosmetic in the policy (e.g., routine facial gender-affirming procedures considered cosmetic, hair removal except for limited preoperative graft preparation, and multiple breast augmentations beyond medically necessary replacement).
- Claims for procedures listed as cosmetic or not medically necessary may be denied
- Elective procedures without documented medical necessity or required documentation are denial triggers
Incorrect CPT Use for Mastectomy (Billing Guidance)
Do not routinely bill mastectomy codes intended for breast cancer (e.g., CPT 19303) for chest masculinization (female-to-male) procedures. Reduction mammaplasty codes (e.g., CPT 19318) describe the work typically performed for chest masculinization and include nipple/areola work that may be incidental to the procedure; use the code that accurately reflects the work performed.
Incorrect Use of Nipple Reconstruction Code (Billing Guidance)
Do not report CPT 19350 (nipple/areola reconstruction) at the same operative session when the work performed is included in the primary reduction/mastectomy/reconstruction code (e.g., CPT 19318). CPT 19350 describes a separate, more involved nipple construction and is generally an incidental-to edit when billed with codes such as 19318.
- CPT 19350 is typically incidental to CPT 19318 and should not be separately reported when nipple/areola modification is part of the primary procedure
- When true nipple reconstruction as defined by CPT 19350 is performed as a distinct procedure, document the additional work to support separate reporting
Procedure-Specific Documentation Requirements
Provide procedure-specific documentation to support the chosen CPT/HCPCS code(s) and to describe the extent of work performed. Include operative reports that detail surgical technique, structures addressed, and any grafting or implant work to justify the selected codes.
- Operative report describing technique, tissues removed or preserved, grafts, implants, and intraoperative findings
- If unlisted codes are used, include detailed operative note and rationale for code selection
Mental Health Evaluation and Provider Qualifications
A signed letter from a qualified mental health professional documenting readiness for physical treatments and assessment of marked and sustained gender dysphoria is required for most gender-affirming surgeries. The mental health professional must meet the qualifications described in the Appendix (WPATH SOC-8 guidance).
- Signed readiness assessment letter from a qualified mental health professional (see Appendix for qualifications)
- Documentation of marked and sustained gender dysphoria per DSM-5 criteria
Surgical and Adolescent Provider Qualifications
Surgeons performing gender-affirming procedures should have documented training and experience in gender-affirming surgery, maintain an active practice and outcome tracking, and engage in continuing education per WPATH SOC-8. Providers who treat adolescents must meet the Appendix qualifications for adolescent care.
- Surgeon documentation of training/supervision in gender-affirming procedures and maintenance of active practice
- Adolescent care providers should have postgraduate pediatric/adolescent expertise and training in gender identity development
Hormone Therapy Prerequisites (Provider Action)
Hormone therapy prerequisites must be documented when required by the procedure-specific criteria: typically six months of continuous hormone therapy for adults (12 months for adolescents under 18) as appropriate to the member’s gender goals, unless hormone therapy is not desired or is medically contraindicated.
- Document duration and type of hormone therapy when required (e.g., 6 months feminizing therapy prior to breast augmentation; 6 months appropriate therapy for other procedures)
- If hormone therapy was not desired or was medically contraindicated, include documentation supporting that exception
Preoperative Hormone Therapy Recommendation for Breast Augmentation
For transfeminine persons undergoing breast augmentation, document completion of feminizing hormone therapy for a minimum of six months prior to augmentation (12 months for adolescents), unless hormones are not desired or medically contraindicated. This preoperative hormone therapy is recommended to maximize breast growth and optimize surgical results.
- Record start and end dates of feminizing hormone therapy and any clinical rationale for exceptions
- Preoperative hormone therapy documentation supports clinical decision-making and prior authorization reviews
Required Clinical Documentation for Authorization
Include the following required clinical documentation with requests for authorization: signed mental health readiness letter, documentation of marked and sustained gender dysphoria (DSM-5 criteria), exclusion of other causes of incongruence, assessment of mental/physical comorbidities and capacity to consent, and cancer-risk assessment when applicable. For adolescents, include documentation of hormone therapy duration or contraindication.
- Signed readiness letter from qualified mental health professional
- DSM-5–based documentation of marked and sustained gender dysphoria
- Assessment of other causes, comorbidities, capacity to consent, and cancer risk factors
- Hormone therapy documentation or rationale for exceptions for adolescents
Coverage Administration Note
Coverage decisions and prior authorization processing are administered per the member’s benefit plan and may be further informed by Clinical Policy Bulletins (CPBs). Always reference the applicable CPBs and the member’s plan documents when determining coverage eligibility.
- Verify applicability of related CPBs (e.g., implant removal, cosmetic surgery) to the member’s claim
- Confirm member-specific plan coverage, exclusions, and prior authorization pathways
Clinical Background and Evidence Summary
Gender dysphoria describes the distress or discomfort resulting from incongruence between an individual’s experienced gender and the gender assigned at birth; diagnostic criteria require a marked difference that is persistent for at least 6 months and is associated with clinically significant distress or impairment. Gender-affirming surgery encompasses procedures to change primary and/or secondary sex characteristics (for example, vaginoplasty, phalloplasty, mastectomy, breast augmentation, and facial procedures) and is delivered as part of multidisciplinary care; psychological evaluation and mental health support are integral to preparation and may continue postoperatively.
Clinical background and preparatory recommendations (also relevant here for context)
Background clinical considerations referenced in document (no discrete coverage criteria in this section):
Contextual background to inform clinical decision-making and documentation.
Key Definitions and Diagnostic Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.